Imported-post

Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA. Read More

Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments. Read More

Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity. Read More

In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients. Read More

New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter. Read More

Researchers in the Endocrine Neoplasia Research Laboratory at Vanderbilt University Medical Center have received national recognition for their work to discover better treatments for thyroid cancer. A paper describing their lab work was awarded first place in the Basic Science category at the 2021 Cancer Research Competition. Read More

Researchers across four health care systems, including Vanderbilt University Medical Center, have found that increased depression polygenic scores are associated with increased white blood cell count, highlighting the importance of the immune system in the etiology of depression. Read More

A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression. Read More

A study led by researchers from Vanderbilt University’s Center for Rehabilitation Engineering and Assistive Technology reveals a breakthrough tool to assess the effect of exoskeletons on injury risk. The tool, called Exo-LiFFT, is an interactive calculator that will help companies looking for ways to overcome workforces struggling with musculoskeletal injuries, missed work, and accelerated retirement... Read More

Vanderbilt biomedical engineering professor has developed a prototype headband to measure brain activity that could have widespread application in studying and ultimately treating ADHD and other neurological disorders. The device is lightweight, portable, and inexpensive to construct. Prototype components cost less than $250, compared to costs exceeding $10,000 for commercial systems. Audrey Bowden, associate professor... Read More